Akero Therapeutics, Inc. Long-Term Debt, Maturity, Year Five
Akero Therapeutics, Inc. had Long-Term Debt, Maturity, Year Five of $1.54 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2024-02-29
- 2023-12-31: Long-Term Debt, Maturity, Year Five $1.54M.
- 2022-12-31: Long-Term Debt, Maturity, Year Five $396.00K.
- 2022-09-30: Long-Term Debt, Maturity, Year Five $387.00K.
- 2022-06-30: Long-Term Debt, Maturity, Year Five $377.00K.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2023-12-31 | $1.54M 10-K · filed 2024-02-29 |
| 2022-12-31 | $396.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $387.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $377.00K 10-Q · filed 2022-08-05 |